The benefits and savings from publicly funded clinical trials of prescription drugs

International Journal of Health Services

Volumn 38, Issue 4, 2008, Pages 731-750

  Baker, Dean ^a  

^a Center for Economic and Policy Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

COST-BENEFIT ANALYSIS; DRUG; HEALTH EXPENDITURE; HEALTH SERVICES; INCENTIVE; PUBLIC HEALTH;

DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; DRUG SCREENING; FUNDING; HUMAN; MEDICARE; PUBLIC HEALTH SERVICE; REVIEW;

ACCESS TO INFORMATION; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; COSTS AND COST ANALYSIS; DRUG APPROVAL; DRUG EVALUATION; DRUG INDUSTRY; DRUGS, INVESTIGATIONAL; EFFICIENCY, ORGANIZATIONAL; FINANCING, GOVERNMENT; HUMANS; PATENTS AS TOPIC; POLITICS; RESEARCH SUPPORT AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 57749196402     PISSN: 00207314     EISSN: 15414469     Source Type: Journal    
DOI: 10.2190/HS.38.4.i     Document Type: Review

References (23)

1. Turner, E., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N. Engl. J. Med. 358:252-260, 2008.
2. Bodenheimer, T. Conflict of Interest in Clinical Drug Trials: A Risk Factor for Scientific Research. Paper presented at the National Institutes of Health Conference on Conflicts of Interest in Scientific Research, August 15, 2000.
3. Cho, M. K., and Bero L. A. The quality of drug studies published in symposium proceedings. Ann. Intern. Med. 124:485-489, 1996.
4. Friedberg, M., et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 282:1453-1457, 1998.
5. Stelfox, H. T., et al. Conflict of interest in the debate over calcium-channel antagonists. N. Engl. J. Med. 338:101-106, 1998.
6. Andersen, M., Kragstrup, J., and Søndergaard, J. How conducting a clinical trial affects physicians' guideline adherence and drug preferences. JAMA 295:2759-2764, 2006.
7. Harris, G. As doctors write prescriptions, drug company writes a check. New York Times, June 27, 2004.
8. Eichenwald, K., and Kolata, G. Drug trials hide conflicts for doctors. New York Times, May 16, 1999.
9. Eichenwald, K., and Kolata, G. A doctor's drug trials turn into fraud. New York Times, May 17, 1999.
10. Lewis, T., Reichman, J., and So, A. The case for public funding and public oversight of clinical trials. Economists' Voice 4(1), 2007.
11. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. CDER NDAs Approved in Calendar Years 1990-2004 by Therapeutic Potential and Chemical Type. www.fda.gov/cder/rdmt/pstable.htm.
12. Dimasi J., Hansen, R., and Grabowski, H. The price of innovation: New estimates of drug development costs. J. Health Econ. 22:151-185, 2003.
13. Hubbard, T., and Love, J. A new trade framework for global healthcare R&D. PLoS Biol 2(2), 2004. www.plosbiology.org/plosonline.
14. Congressional Budget Office. Research and Development in the Pharmaceutical Industry. Washington, DC, 2006. www.cbo.gov/ftpdocs/76xx/ doc7615/10-02-DrugRD.pdf.
15. Love, J. Evidence Regarding Research and Development Investment in Innovative and Non-Innovative Medicines. Consumer Project on Technology, Washington, DC, 2003.
16. Congressional Budget Office. Would Prescription Drug Importation Reduce U.S. Drug Spending? Washington, DC, 2004. www.cbo.gov/ftpdocs/54xx/ doc5406/04-29-PrescriptionDrugs.pdf.
17. U.S. Department of Commerce, International Trade Commission. Pharmaceutical Price Controls in OECD Countries. Washington, DC, 2004. www.ita.doc.gov/td/health/DrugPricingStudy.pdf.
18. Congressional Budget Office. A Detailed Description of CBO's Cost Estimate for the Medicare Prescription Drug Plan, table 7 and endnote 11. Washington, DC, 2004. www.cbo.gov/ftpdoc.cfm?index=5668&type=0;www.cbo.gov/ showdoc.cfm?index=5668&sequence=2#F11.
19. Centers for Medicare and Medicaid Services. National Health Expenditure Projections, 2006-2016, Table 11. Washington, DC, 2007. www.cms.hhs.gov/NationalHealthExpendData/downloads/proj2006.pdf.
20. Donohue, J., Cevasco, M., and Rosenthal, M. A decade of direct-to-consumer advertising of prescription drugs. N. Engl. J. Med., August 16, 2007, pp. 673-681.
21. Saul, S. Gimme an Rx! Cheerleaders pep up drug sales. New York Times, November 28, 2005.
22. Medicare Payment Advisory Commission. How Beneficiaries Learned about the Drug Benefit and Made Plan Choices, Table 8-4. 2006. www.medpac.gov/ publications/congressional_reports/Jun06_Ch08.pdf.
23. Mishel, L., Bernstein, J., and Allegretto, S. The State of Working America, 2007-2008. Cornell University Press, Ithaca, NY, 2007.